PEPTIDE HISTIDINE VALINE (PHV) IS PRESENT AND BIOLOGICALLY-ACTIVE IN THE HUMAN FEMALE GENITAL-TRACT

被引:25
作者
PALLE, C
OTTESEN, B
FAHRENKRUG, J
机构
[1] BISPEBJERG HOSP,DEPT CLIN CHEM,DK-2400 COPENHAGEN,DENMARK
[2] HERLEV CTY HOSP,DEPT OBSTET & GYNAECOL,COPENHAGEN,DENMARK
关键词
FEMALE GENITAL TRACT; PEPTIDE DISTRIBUTION; SMOOTH MUSCLE ACTIVITY; PEPTIDE HISTIDINE VALINE;
D O I
10.1016/0167-0115(92)90048-Y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The occurrence of vasoactive intestinal polypeptide (VIP), peptide histidine methionine (PHM) and peptide histidine valine (PHV) in the human female genital tract was studied by means of radioimmunoassay in combination with gel chromatography. In addition, the effect of PHV on genital smooth muscle activity was investigated and compared to that of VIP. Immunoreactive VIP, PHM and PHV were present in all regions of the human female genital tract, the highest concentrations being measured in the vagina and the uterine cervix. The peptides displayed similar regional distribution and as expected from the structure of the VIP precursor molecule in which the examined peptides are contained, the molar ratio of VIP to the total PHM/PHV immunoreactivity was close to 1:1. In all regions PHV constituted 50-70% of the total PHM/PHV immunoreactivity indicating that the dibasic conversion site after PHM was uncleaved. VIP and PHV were found to be equipotent relaxants of the smooth muscle from the Fallopian tube and the myometrium. The present study indicates that PHV like PHM and VIP may act as a neurotransmitter in the human female genital tract and thus participate in the local nervous control of the reproductive functions.
引用
收藏
页码:101 / 109
页数:9
相关论文
共 23 条
[1]   PEPTIDES PHI AND VIP - COMPARISON BETWEEN VASCULAR AND NONVASCULAR SMOOTH-MUSCLE EFFECT IN RABBIT UTERUS [J].
BARDRUM, B ;
OTTESEN, B ;
FAHRENKRUG, J .
AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 251 (01) :E48-E51
[2]   THE DISTRIBUTIONS OF PHI AND VIP IN PORCINE GUT AND THEIR CO-LOCALIZATION TO A PROPORTION OF INTRINSIC GANGLION-CELLS [J].
BISHOP, AE ;
POLAK, JM ;
YIANGOU, Y ;
CHRISTOFIDES, ND ;
BLOOM, SR .
PEPTIDES, 1984, 5 (02) :255-259
[3]  
BLANK MA, 1986, INT J FERTIL, V31, P218
[4]   DISTRIBUTION OF PEPTIDE HISTIDINE ISOLEUCINE IN THE MAMMALIAN RESPIRATORY-TRACT AND SOME ASPECTS OF ITS PHARMACOLOGY [J].
CHRISTOFIDES, ND ;
YIANGOU, Y ;
PIPER, PJ ;
GHATEI, MA ;
SHEPPARD, MN ;
TATEMOTO, K ;
POLAK, JM ;
BLOOM, SR .
ENDOCRINOLOGY, 1984, 115 (05) :1958-1963
[5]   CHARACTERIZATION AND REGIONAL DISTRIBUTION OF PEPTIDES DERIVED FROM THE VASOACTIVE INTESTINAL PEPTIDE PRECURSOR IN THE NORMAL HUMAN-BRAIN [J].
FAHRENKRUG, J ;
EMSON, PC .
JOURNAL OF NEUROCHEMISTRY, 1989, 53 (04) :1142-1148
[6]   EVIDENCE FOR COMMON PRECURSORS BUT DIFFERENTIAL PROCESSING OF VIP AND PHM IN VIP-PRODUCING TUMORS [J].
FAHRENKRUG, J .
PEPTIDES, 1985, 6 (03) :357-361
[7]   COSECRETION OF PEPTIDE HISTIDINE METHIONINE (PHM) AND VASOACTIVE-INTESTINAL-PEPTIDE (VIP) IN PATIENTS WITH VIP-PRODUCING TUMORS [J].
FAHRENKRUG, J ;
PEDERSEN, JH .
PEPTIDES, 1986, 7 (05) :717-721
[8]   VIP AND PHI IN CAT NEURONS - CO-LOCALIZATION BUT VARIABLE TISSUE CONTENT POSSIBLE DUE TO DIFFERENTIAL PROCESSING [J].
FAHRENKRUG, J ;
BEK, T ;
LUNDBERG, JM ;
HOKFELT, T .
REGULATORY PEPTIDES, 1985, 12 (01) :21-34
[9]   DEVELOPMENT AND VALIDATION OF A SPECIFIC RADIOIMMUNOASSAY FOR PHI IN PLASMA [J].
FAHRENKRUG, J ;
PEDERSEN, JH .
CLINICA CHIMICA ACTA, 1984, 143 (03) :183-192
[10]  
FAHRENKRUG J, 1987, SCAND J CLIN LAB INV, V47, P43